Apollo Hospitals Enterprise Limited has scheduled a meeting of its unsecured creditors for June 24, 2026, at 11:00 a.m., to consider and approve a composite scheme of arrangement. This significant corporate restructuring involves the demerger of its Identified Business Undertaking into a resultant company, alongside the amalgamation of two transferor companies. The meeting will be held virtually via video conferencing and remote e-voting will be available from June 20 to June 23, 2026.
Overview of the Scheme
The proposed composite scheme of arrangement aims to streamline the company’s business structure. The plan includes the demerger of the company’s Identified Business Undertaking into a new entity, Apollo Healthtech Limited (the Resultant Company). Furthermore, the scheme entails the amalgamation of two transferor entities—Apollo Healthco Limited and Keimed Private Limited—into the Resultant Company. This strategic move is intended to enable operational efficiencies and provide a more focused growth trajectory for the digital health and pharmacy distribution businesses.
Key Meeting Information
The meeting for unsecured creditors is set for Wednesday, June 24, 2026, at 11:00 a.m. (IST). Given the current corporate governance standards, this session will be conducted entirely through Video Conferencing (VC) and Other Audio Visual Means (OAVM). Unsecured creditors as per the records on the cut-off date of December 31, 2025, are entitled to exercise their voting rights.
Voting Procedures
To ensure widespread participation, the company has provided a remote e-voting facility. Creditors may cast their votes between 9:00 a.m. (IST) on June 20, 2026, and 5:00 p.m. (IST) on June 23, 2026. Additionally, an e-voting facility will be available during the meeting itself for those who have not yet voted. The voting results will be finalized following the review by the appointed Scrutinizer and will be announced within two working days of the meeting’s conclusion.
Strategic Rationale and Benefits
The board of directors believes this restructuring will unlock significant value for all stakeholders. By consolidating the pharmacy distribution businesses into an independent, focused company, Apollo Hospitals expects to capture synergies, improve administrative efficiency, and achieve economies of scale. The Resultant Company is expected to build a wider capital and financial base, thereby attracting a new set of strategic partners and investors to support its long-term expansion in the digital healthcare space.
Source: BSE
